Philip B. Donenberg
Chief Financial Officer, ANI PHARMACEUTICALS INC.
Companies
- Faeth Therapeutics, Inc.Board member Feb 17, 2026 to now1
- Taysha Gene Therapies, Inc.Board member Sep 23, 2020 to now2
- Tectonic Therapeutic, Inc.Board member Jun 20, 2018 to now3
- CervoMed Inc.Board member Jul 29, 2014 to Jul 29, 20144
- CervoMed Inc.Chief financial officer Jun 6, 2014 to Jun 6, 20145
- ANI PHARMACEUTICALS INCChief financial officer Mar 20, 2006 to Jan 27, 20126
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Taysha Gene Therapies, Inc. TSHA241,289 shares7$954.3K at $3.96Jun 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 1, 2026Granted 21,335 shares of Taysha Gene Therapies, Inc.7
- Jun 2, 2025Granted 56,623 shares of Taysha Gene Therapies, Inc.8
- May 29, 2024Granted 49,220 shares of Taysha Gene Therapies, Inc.9
- Aug 16, 2023Bought 111,111 shares at $0.90 of Taysha Gene Therapies, Inc.10
- Feb 2, 2022Bought 3,000 shares at $7.78 of Taysha Gene Therapies, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARCervoMed Inc., Board member
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Jun 4, 2025
- 9SEC EDGARForm 4 filed May 31, 2024
- 10SEC EDGARForm 4 filed Aug 16, 2023
- 11SEC EDGARForm 4 filed Feb 3, 2022